Chronic Lymphocytic Leukemia (CLL), Hodgkin and non Hodgkin lymphomas
Dr. Oluwole specializes in the treatment of malignant hematologic disorders with research focus on Chronic Lymphocytic Leukemia (CLL), Hodgkin and non Hodgkin lymphomas. He is engaged in clinical trials using targeted therapies aimed at improving treatment outcomes in patients with hematologic malignancies. He also serves as a portfolio coach at Vanderbilt University School of Medicine (VUSM) where he guides individual medical students in developing the skills for informed self-assessment and life-long learning.
Dr. Oluwole received his MBBS from University of Ibadan, Nigeria and a Master of Public Health degree at the University of Medicine and Dentistry of New Jersey. His residency was in Internal Medicine at Morehouse. He completed his Hematology/Oncology fellowship at Vanderbilt in 2011 and has been on faculty since that time.
He has authored or co-authored research articles in peer reviewed journals and written a book chapter. He is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and American College of Physicians (ACP).